PRKAA1 and metabolic dysfunction-associated steatohepatitis: Nicotine accumulation in the gut activates AMPKα1 phosphorylation, which is bound to sphingomyelin phosphodiesterase 3 (SMPD3), a key enzyme in the ceramide biosynthesis pathway, and exacerbates NASH progression.